Investor Event

ShareSoc Webinar with Silence Therapeutics (SLN)
11 November 2020

Presenter:
Mark Rothera, President and CEO

Company: Silence Therapeutics (SLN)
Date:
 11th November 2020
Time: 5pm – 6pm
Presenter: Mark Rothera, President and CEO
Format: Webinar

Company Information: Silence Therapeutics is developing a new generation of medicines by harnessing the body’s natural mechanism of RNA interference, or RNAi, to inhibit the expression of specific target genes thought to play a role in the pathology of diseases with significant unmet medical need. Silence’s proprietary technology can be used to engineer short interfering ribonucleic acids (siRNAs) that bind specifically to and silence, through the RNAi pathway, almost any gene in the human genome to which siRNA can be delivered. Silence is currently focused on developing siRNA molecules for the potential treatment of cardiovascular disease, rare diseases such as iron overload disorders, and complement-mediated disorders.

Registration

This is a 3 step process:
1) Log in to your ShareSoc account or Join ShareSoc for free
2) Click ‘Submit’ on the form below
3) Click on the link on the next page to register with GoToWebinar to COMPLETE THE REGISTRATION

Once you have registered fully with GoToWebinar you will receive an email notification, as well as reminders 1 day and 1 hour before the event starts.

Add to calendar
Event Details:
  • Event: ShareSoc Webinar with Silence Therapeutics (SLN) - 11 November 2020
  • Date: 11/11/2020
  • Time: Presentation Starts at 5pm
  • Location: Webinar
Add to calendar
Event Details:
  • Event ShareSoc Webinar with Silence Therapeutics (SLN) - 11 November 2020
  • Date 11/11/2020
  • Time Presentation Starts at 5pm
  • Location Webinar
  • Description Presenter:
    Mark Rothera, President and CEO